Should third-generation cephalosporins be avoided against AmpC-inducible Enterobacteriaceae?

David M. Livermore; Derek F. J. Brown; John P. Quinn; Yehuda Carmeli; David L. Paterson; Victor L. Yu

doi:10.1111/j.1469-0691.2004.00831.x

Should third-generation cephalosporins be avoided against AmpC-inducible Enterobacteriaceae?

David M. Livermore, Derek F. J. Brown, John P. Quinn, Yehuda Carmeli, David L. Paterson, Victor L. Yu

Research output: Contribution to journal › Article › peer-review

32 Citations (Scopus)

Original language	English
Pages (from-to)	84-85
Number of pages	2
Journal	Clinical Microbiology and Infection
Volume	10
Issue number	1
DOIs	https://doi.org/10.1111/j.1469-0691.2004.00831.x
Publication status	Published - Jan 2004

Keywords

Cephalosporin Resistance
Cephalosporinase
Cephalosporins
Enterobacteriaceae
Enterobacteriaceae Infections
Enzyme Induction
Humans

Access to Document

10.1111/j.1469-0691.2004.00831.x

Cite this

@article{9de295edbbb34b00811dbd133fad5173,

title = "Should third-generation cephalosporins be avoided against AmpC-inducible Enterobacteriaceae?",

keywords = "Cephalosporin Resistance, Cephalosporinase, Cephalosporins, Enterobacteriaceae, Enterobacteriaceae Infections, Enzyme Induction, Humans",

author = "Livermore, {David M.} and Brown, {Derek F. J.} and Quinn, {John P.} and Yehuda Carmeli and Paterson, {David L.} and Yu, {Victor L.}",

year = "2004",

month = jan,

doi = "10.1111/j.1469-0691.2004.00831.x",

language = "English",

volume = "10",

pages = "84--85",

journal = "Clinical Microbiology and Infection",

issn = "1198-743X",